115 related articles for article (PubMed ID: 2100733)
21. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
22. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
[TBL] [Abstract][Full Text] [Related]
23. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of fluconazole on Candida albicans.
Abecia LC; Arévalo JM; López MJ
Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
[TBL] [Abstract][Full Text] [Related]
25. Rapid identification of fluconazole resistance using Chromagar Candida.
Verghese SL; Padmaja P; Sutha P; Mathew T; John ES
Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683
[TBL] [Abstract][Full Text] [Related]
26. Rapid identification of fluconazole resistance using Chrom agar Candida.
Verghese SL; Padmaja P; Sutha P; Mathew T; Johni ES
Indian J Pathol Microbiol; 2001 Jul; 44(3):305-7. PubMed ID: 12024918
[TBL] [Abstract][Full Text] [Related]
27. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
Yang YL; Li SY; Cheng HH; Lo HJ;
Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
[TBL] [Abstract][Full Text] [Related]
28. Preparations of liposomal fluconazole and their in vitro antifungal activity.
Singh M; Singh MP; Maiti SN; Gandhi A; Micetich RG; Atwal H
J Microencapsul; 1993; 10(2):229-36. PubMed ID: 8331496
[TBL] [Abstract][Full Text] [Related]
29. In vitro synergistic activity of ketoconazole with valproic acid against Candida species.
Krajewska-Kułak E; Niczyporuk W
Arzneimittelforschung; 1996 Sep; 46(9):934-6. PubMed ID: 8876946
[TBL] [Abstract][Full Text] [Related]
30. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
Fujita S
Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
[TBL] [Abstract][Full Text] [Related]
31. [Antifungal activity of fluconazole in vitro].
Pawlik B; Macura AB
Med Dosw Mikrobiol; 1995; 47(1-2):101-6. PubMed ID: 8523965
[TBL] [Abstract][Full Text] [Related]
32. Fluconazole, itraconazole and ketoconazole in vitro activity against Candida spp.
Arévalo MP; Arias A; Andreu A; Rodríguez C; Sierra A
J Chemother; 1994 Aug; 6(4):226-9. PubMed ID: 7830098
[TBL] [Abstract][Full Text] [Related]
33. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
Uchida K; Matsuzaka A; Aoki K; Yamaguchi H
Jpn J Antibiot; 1991 May; 44(5):562-70. PubMed ID: 1652654
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.
Wardle HM; Law D; Moore CB; Mason C; Denning DW
Antimicrob Agents Chemother; 1995 Apr; 39(4):868-71. PubMed ID: 7785986
[TBL] [Abstract][Full Text] [Related]
35. Antifungal activity of propolis against Candida species isolated from cases of chronic periodontitis.
Siqueira AB; Rodriguez LR; Santos RK; Marinho RR; Abreu S; Peixoto RF; Gurgel BC
Braz Oral Res; 2015; 29():. PubMed ID: 26154370
[TBL] [Abstract][Full Text] [Related]
36. Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.
Arzeni D; Barchiesi F; Ancarani F; Scalise G
J Chemother; 1991 Jun; 3(3):139-42. PubMed ID: 1655990
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates.
Palacín C; Tarragó C; Agut J; Guglietta A
Methods Find Exp Clin Pharmacol; 2001 Mar; 23(2):61-4. PubMed ID: 11484411
[TBL] [Abstract][Full Text] [Related]
38. In vitro susceptibility of clinical yeast isolates to fluconazole and terconazole.
Cooper CR; McGinnis MR
Am J Obstet Gynecol; 1996 Dec; 175(6):1626-31. PubMed ID: 8987951
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of a breakpoint test for determination of fluconazole susceptibility of yeasts].
Fegeler W
Mycoses; 1997; 40 Suppl 1():47-52. PubMed ID: 9417513
[TBL] [Abstract][Full Text] [Related]
40. Slime production and proteinase activity of Candida species isolated from blood samples and the comparison of these activities with minimum inhibitory concentration values of antifungal agents.
Ozkan S; Kaynak F; Kalkanci A; Abbasoglu U; Kustimur S
Mem Inst Oswaldo Cruz; 2005 May; 100(3):319-23. PubMed ID: 16113876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
